研究者

J-GLOBAL ID：201901018702120600 更新日: 2024年07月17日

宮﨑涼平

ミヤザキリョウヘイ | Ryohei Miyazaki

競争的資金等の研究課題 (1件)：

2012 - 2015 肺癌に対するPorphysome増感併用による気管支鏡下光温熱治療の開発

論文 (5件)：

Takashi Anayama, Kentaro Hirohashi, Ryohei Miyazaki, Hironobu Okada, Marino Yamamoto, Kazumasa Orihashi. Fluorescence visualization of the intersegmental plane by bronchoscopic instillation of indocyanine green into the targeted segmental bronchus: determination of the optimal settings. Journal of International Medical Research. 2021. 49. 2
Masahiko Higashiyama, Ryohei Miyazaki, Hiroshi Yamamoto, Takashi Anayama, Shinya Kikuchi, Kentaro Hirohashi, Jiro Okami, Tomohiro Maniwa, Toru Kimura, Kazumasa Orihashi, et al. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer. BMC cancer. 2020. 20. 1. 1100-1100
Takashi Anayama, Takayuki Sato, Kentaro Hirohashi, Ryohei Miyazaki, Marino Yamamoto, Hironobu Okada, Kazumasa Orihashi, Keiji Inoue, Michiya Kobayashi, Masashi Yoshida, et al. Near-infrared fluorescent solid material for visualizing indwelling devices implanted for medical use. Surgical endoscopy. 2020. 34. 9. 4206-4213
Takashi Anayama, Masahiko Higashiyama, Hiroshi Yamamoto, Shinya Kikuchi, Atsuko Ikeda, Jiro Okami, Toshiteru Tokunaga, Kentaro Hirohashi, Ryohei Miyazaki, Kazumasa Orihashi. Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrence. Scientific reports. 2018. 8. 1. 12378-12378
Ryohei Miyazaki, Takashi Anayama, Kentaro Hirohashi, Hironobu Okada, Motohiko Kume, Kazumasa Orihashi. In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer (vol 11, e0152665, 2016). PLOS ONE. 2016. 11. 11. e0152665

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM